Omada Health, Inc. OMDA
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 12.54% | 2.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.54% | 2.90% | |||
| Cost of Revenue | -18.08% | 32.33% | |||
| Gross Profit | 31.00% | -9.26% | |||
| SG&A Expenses | 11.86% | 5.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.76% | 14.14% | |||
| Operating Income | 174.23% | -245.72% | |||
| Income Before Tax | 278.25% | -157.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 278.25% | -157.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 278.25% | -157.57% | |||
| EBIT | 174.23% | -245.72% | |||
| EBITDA | 256.74% | -169.23% | |||
| EPS Basic | 275.99% | -156.69% | |||
| Normalized Basic EPS | 275.87% | -156.76% | |||
| EPS Diluted | 258.73% | -162.45% | |||
| Normalized Diluted EPS | 264.13% | -162.50% | |||
| Average Basic Shares Outstanding | 1.29% | 1.49% | |||
| Average Diluted Shares Outstanding | 8.53% | -7.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||